📉🏥Buying When Conviction Is Uncomfortable
Sharp drawdowns rarely signal broken businesses. More often, they signal policy ambiguity, temporary margin pressure, and investor impatience. Healthcare, more than most sectors, absorbs these shocks first—because it sits at the intersection of regulation, demographics, and cost inflation.
Right now, two healthcare names are being repriced aggressively, not because demand is declining, but because the system around them is in flux. Coverage rules are debated. Subsidies are questioned. Utilization has spiked. Headlines are loud.
For the investor who doesn’t have time to monitor every legislative development, this moment requires a different filter:
Is the business model adaptable when the rules shift?
Is management planning for disruption—or reacting to it?
This distinction separates temporary drawdowns from structural breakdowns.
Oscar Health and UnitedHealth sit on opposite ends of the size and maturity spectrum, yet both reflect the same market behavior: pricing fear first, clarity later. Historically, this is where long-term capital begins to work—quietly, without urgency.
Oscar Health: A Scaled Revenue Engine Priced Like a Fragile Startup
Oscar Health’s valuation disconnect begins with a simple mismatch: scale without profitability—yet.
With a market capitalization near $4 billion and expected annual revenue approaching $12 billion, the company trades well below a 1x price-to-sales ratio. In isolation, this appears irrational. In context, it reflects skepticism around margins, regulatory exposure, and historical volatility.
Oscar operates predominantly within the ACA individual marketplace, making it sensitive to the expiration of enhanced subsidies. Those subsidies are expected to lapse, not the ACA itself—a crucial distinction often lost in headline risk.
Rather than wait for clarity, Oscar has already acted:
• 2026 pricing assumes subsidies expire, incorporating a 28% weighted-average rate increase
• $60 million in administrative cost reductions are being implemented
• Capital allocation has been defensive, preserving liquidity
• Competitor retreat is expected—and planned for
Management is effectively betting that survival during contraction creates opportunity during consolidation.
The long-term opportunity remains substantial. The individual insurance market is projected to expand materially over the next decade, potentially covering up to 120 million Americans, including gig workers, small businesses, part-time employees, and segments traditionally underserved by employer-sponsored plans.
Oscar’s technology-first model—particularly its use of AI for claims processing, member engagement, and utilization management—allows it to operate with a lower cost structure than legacy insurers. In an environment where margins matter more than growth, efficiency becomes leverage.
The Risk Oscar Bears—and Why It’s Being Understood, Not Ignored
Oscar’s risk profile is real and measurable.
Medical Loss Ratio climbed to 88.5%, up 380 basis points year-over-year, reflecting rising utilization and healthcare inflation. Risk adjustment payments for 2025 increased by approximately $130 million, exposing the company to adverse risk pool shifts if healthier members exit the system.
These are not theoretical risks. They are happening.
What matters is response.
Despite margin pressure, revenue grew 23% year-over-year, while membership increased 28%, signaling demand resilience. Importantly, SG&A declined to 17.5%, moving closer to the company’s long-term target of ~16%. Revenue growth continues to outpace overhead.
Oscar also holds over $1 billion in excess capital and has been actively cleaning up debt—critical for navigating policy-driven volatility.
The bull case does not rely on perfect conditions. It relies on outlasting less efficient competitors during a turbulent period and emerging with greater share when the market stabilizes. The bear case assumes cost inflation overwhelms efficiency gains faster than pricing power can adjust.
This is asymmetrical by design: uncomfortable in the short term, potentially transformational if execution continues.
UnitedHealth: When Scale Absorbs the Shock
UnitedHealth’s drawdown tells a different story—one of reset, not retreat.
Valued around $300 billion, UnitedHealth has been pressured by Medicare reimbursement cuts, elevated utilization, and margin compression within Optum. The stock declined sharply, at one point trading near $240, reflecting fears of sustained profitability erosion.
Yet structurally, UnitedHealth is far less exposed to ACA volatility than smaller peers. The majority of its $57 billion in individual and employer revenues originate from corporate-sponsored plans, insulating it from subsidy-driven disruption.
Management has been explicit: 2026 is a reset year.
• Medicare Advantage enrollment will contract by ~1 million members
• ACA exposure will be reduced
• Short-term earnings are sacrificed to restore margin integrity
• Earnings growth is expected to resume in 2026
• Double-digit EPS growth projected for 2027
Commercial insurance margins are expected to normalize between 7–9%, restoring a profitability profile consistent with UnitedHealth’s historical strength.
Political rhetoric around affordability introduces headline risk but rarely dismantles diversified incumbents. UnitedHealth’s scale, lobbying power, and operational depth allow it to absorb regulatory pressure far more effectively than smaller players.
This is not a growth story. It is a valuation repair anchored in durability.
Two Paths Through the Same Uncertainty
Oscar Health and UnitedHealth represent two responses to the same environment:
• One survives through agility and efficiency
• The other endures through scale and diversification
Oscar offers asymmetrical upside, tied to execution, market consolidation, and a growing individual insurance ecosystem. UnitedHealth offers stability and recovery, priced as if disruption were permanent rather than cyclical.
Neither depends on optimism. Both depend on discipline.
For investors with limited time and high cognitive load, the takeaway is not to choose sides emotionally—but to recognize what kind of uncertainty is being priced in.
Markets routinely over-discount discomfort. When clarity returns—as it always does—capital tends to flow back toward businesses that prepared rather than panicked.
This is not about timing the bottom. It is about understanding which companies planned for disruption before it arrived—and positioning accordingly.
Want More Investing Tips?
 |
$5.00
We love coffee
At Investing Wise Academy, we’re passionate about fueling our community with great content and a good cup of coffee! Our... Read more |
We’re here to guide you through every step of your investing journey!
We can also help you BUILD a WINNING PORTFOLIO in just 10 MINUTES! We will provide a step-by-step guide to effortless investing in the stock market on autopilot. Copy the portfolio and grow your wealth. Get our FREE Portfolio by joining our newsletter. You can also get regular updates, tips, and exclusive content on making the most of your investments and building lasting wealth!
Subscribe Now to Receive More Investing Tips!
Thank you for reading, and remember: Investing today is the key to your financial freedom today and tomorrow.
Let’s build wealth one step at a time!
